Category: Oncology
Department of Medicine Grants & Funding: February 1 – February 28, 2022
Division of Infectious Diseases David L. Rosen, MD, PhD, MSPH, received a $580,000 Duke Endowment Award to compare the impact of transition-to-care service programs on healthcare utilization and mortality among people with chronic health conditions released from the NC state prison system. Division of Oncology Brian C. Miller, MD, PhD, received a $700,000 Burroughs Wellcome Grant … Read more
Carey Discussed Studies of HR-Positive and HER2-Negative Advanced Breast Cancer: Overall Survival by Subtype Across Three MONALEESA Studies
Lisa A. Carey, MD, FASCO, the L. Richardson and Marilyn Jacobs Preyer Distinguished Professor for Breast Cancer Research, Division of Oncology and Deputy Director of Clinical Sciences for the Lineberger Comprehensive Cancer Center, discusses findings from a pooled analysis of the MONALEESA-2, -3, and -7 trials. Among the findings was a consistent overall survival benefit with rib … Read more
Newsworthy From the Department of Medicine, Week of November 29 – December 2
UNC researchers working to learn more about omicron variant as 1st case is identified in US – Drs. Melissa Miller and David Wohl (CBS 17) Worried about omicron? COVID’s delta strain remains a bigger threat, UNC doctors say – Drs. Melissa Miller and David Wohl (Charlotte Observer) COVID-19 Mask Recommendations Open New Chapter in Cover Story – Dr. Emily Sickbert-Bennett (Noozhawk) … Read more
Department of Medicine Grants & Funding: October 1 – October 31, 2021
Division of Geriatric Medicine John Batsis, MD, was awarded a grant from NC TraCS to study early detection of sarcopenia in collaboration with David Lynch, MBBS. Division of Oncology Lisa Carey, MD, received a grant from the Breast Cancer Research Foundation for “Clinical implications of metastatic subtype, microenvironment, and organ of involvement.” Division of Rheumatology, Al … Read more
Hematology/Oncology Diversity and Inclusion Initiatives
UNC Lineberger Comprehensive Cancer Center Equity Council Four members of the Department of Medicine are working to bring diversity, equity and inclusion principles into critical areas of UNC Lineberger. “This is a group of 14 faculty, graduate students, and staff–and we’re in the process of identifying patients and community members–coming together to develop a system that mea … Read more
Breast Cancer Awareness Month–Caring for Patients, Advancing Research
Behind every photo is a story with the power to uplift and inspire. One year has made all the difference for Frances Lucas from Fayetteville, who was diagnosed with breast cancer in May 2020. And, it was something Dr. Yara Abdou said that set the tone for her journey. “She said, ‘I’m not only going to be your doctor, I want to be your friend,’ ” recalls Frances from her first app … Read more
Muss Receives Three Research Grant Awards
Hyman Muss, MD, the Mary Jones Hudson Distinguished Professor of Geriatric Oncology in the Division of Oncology, recently received three research awards. From the Breast Cancer Research Foundation (BCRF), Muss received $190,000 in funding for “p16INK4a Expression, Chemotherapy Toxicity, and Aging in Women with Breast Cancer.” There is significant variability in chemotherapy-relat … Read more
Department of Medicine Grants & Funding: September 1 – September 30, 2021
Division of Gastroenterology and Hepatology Andrea Azcarate-Peril, PhD, received an NC TraCS pilot grant award. Division of Geriatric Medicine Joshua Niznik, PharmD, PhD, received an NC TraCS pilot grant award. UNC’s Center for Aging and Health received a two-year Health Resources and Services Administration (HRSA), Department of Health and Human Services grant (with University o … Read more
Chemotherapy Plus Immunotherapy Before Surgery is Beneficial For Invasive Bladder Cancer Outcomes
A new study is the first to report the beneficial use of chemotherapy plus immunotherapy before surgical removal of the bladder in muscle-invasive bladder cancer (MIBC). Researchers at the UNC Lineberger Comprehensive Cancer Center led the study, reporting that the regimen reduced the invasiveness of the cancer in 56 percent of patients in a phase II clinical trial. The findings … Read more
Roundtable Discussion: Weiss Discusses Treatment of RET-Fusion Mutations in NSCLC
Jared Weiss, MD, associate professor in the division of oncology, led a recent discussion about a 59.year-old patient with RET-fusion-positive non–small cell lung cancer (NSCLC) during a Targeted Oncology Case-Based Roundtable event. Read a transcript of the discussion.
To Boost Covid-19 Vaccine Uptake, Stein Describes Early Strategy To Identify Those Who May Have Missed System-Wide Communication
As public health leaders double down on efforts to get shots to the 30% of eligible people in the U.S. that remain unvaccinated, STAT News featured UNC Health’s unique strategy to reach those who might have fallen through the cracks. During the early days of vaccine rollout “we realized that the vast majority of this communication was being done either by email or by MyChart mess … Read more
-
New Therapies For Elderly, Frail Patients With Head and Neck Cancer
Jared Weiss, MD, associate professor of medicine in the division of oncology, commented on one of two treatment regimens that have shown promise for treating elderly or frail patients with head and neck squamous cell carcinoma, according to researchers. “These results are consistent with those observed in the dose-escalation part of the study and suggest durable efficacy,” said J … Read more